TrialJournal of comparative effectiveness research2026
Indirect treatment comparisons find enhanced effectiveness of pegcetacoplan versus crovalimab in both complement inhibitor-naïve and -experienced patients with paroxysmal nocturnal hemoglobinuria.
Raymond Siu Ming Wong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.